Audited Financial Statements for the year ended 31.03.2026

Results restatedExceptional itemResults View source PDF Explain this filing

JGCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.8%Reaction day

₹418.00

prior close

₹415.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.4%-5.5% vs market

Commodity Chemicals peers, median of 50sector-0.6%-5.2% vs sector

On the reaction day the stock moved 5.5 pts less than Nifty Microcap 250 and 5.2 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.9

10m

-4.8

15m

-4.6

30m

-3.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.8-0.4-5.5-0.6-5.2

Next day

-7.2-1.7-5.5-1.7-5.5

-7.4-1.3-6.1-1.2-6.2

-5.3-0.7-4.6-0.1-5.2

-6.3+0.4-6.7-0.8-5.4

-5.5+0.5-6.0-0.8-4.7

-1.9+2.8-4.7-0.0-1.8

15d

+1.7+1.2+0.5-3.1+4.8

+2.0+5.3-3.3-3.1+5.1

+6.4+9.9-3.5-4.9+11.3

+43.9+13.1+30.8-3.2+47.2

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 50Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

J.G. Chemicals Limited reported audited standalone and consolidated financial results for FY2026 with an unmodified (clean) audit opinion from S. Jaykishan, Chartered Accountants. Consolidated revenue from operations grew to ₹9,729.30 million (up from ₹8,479.44 million in FY2025), while consolidated net profit after tax stood at ₹675.86 million versus ₹663.57 million. The company recommended a final dividend of 11% (₹1.10 per share) subject to shareholder approval. Additionally, ₹42.62 million of IPO proceeds remain unutilized for the R&D Centre due to construction delays, with the company seeking extension until FY2027. The board also re-appointed the Cost Auditor, Internal Auditor, and Tax Auditor for FY2026-27.

Likely market impact

The clean audit opinion and modest profit growth indicate stable performance. The dividend recommendation provides income support for shareholders, while the delayed R&D spending represents a minor execution risk for IPO fund utilization.